Evidence map›Paper›PMID 27783386›Full record

ArticleClinical and experimental immunology2017

Characterization of resident lymphocytes in human pancreatic islets.

M Radenkovic, K Uvebrant, O Skog, L Sarmiento, J Avartsson, P Storm, P Vickman, P-A Bertilsson, M Fex, O Korgsgren and 1 more

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Evolving role of CD8Frontiers in immunology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Abnormal Expression of an Insulin Synthesizing Enzyme in Islets of Adult Autoantibody Positive Donors.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes.Handbook of experimental pharmacology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

M RadenkovicDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
K UvebrantDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
O SkogDepartment of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University Hospital, Uppsala, Sweden.
L SarmientoDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
J AvartssonDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
P StormDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
P VickmanDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
P-A BertilssonDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
M FexDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
O KorgsgrenDepartment of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University Hospital, Uppsala, Sweden.
C M CilioDepartment of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden.
Lund University · SEUppsala University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current view of type 1 diabetes (T1D) is that it is an immune-mediated disease where lymphocytes infiltrate the pancreatic islets, promote killing of beta cells and cause overt diabetes. Although tissue resident immune cells have been demonstrated in several organs, the composition of lymphocytes in human healthy pancreatic islets have been scarcely studied. Here we aimed to investigate the phenotype of immune cells associated with human islets of non-diabetic organ donors. A flow cytometry analysis of isolated islets from perfused pancreases (n = 38) was employed to identify alpha, beta, T, natural killer (NK) and B cells. Moreover, the expression of insulin and glucagon transcripts was evaluated by RNA sequencing. Up to 80% of the lymphocytes were CD3

Indexed as

B-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDiabetes Mellitus, Type 1FemaleHumansInsulinInsulin-Secreting CellsIslets of LangerhansKiller Cells, NaturalMaleMiddle AgedInsulindiabeteshumanmemorypancreasT cells

Identifiers

PMID27783386
PMCPMC5290249
OpenAlexW2542344557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.